Light disinfection system and method

US9937274B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-9937274-B2
Application numberUS-201615065894-A
CountryUS
Kind codeB2
Filing dateMar 10, 2016
Priority dateMar 18, 2015
Publication dateApr 10, 2018
Grant dateApr 10, 2018

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

A lighting system includes a light source configured to generate light toward one or more surfaces or materials to inactivate one or more pathogens on the one or more surfaces or materials. The light includes an inactivating portion having wavelengths in a range of 280 to 380 nanometers.

First claim

Opening claim text (preview).

What is claimed is: 1. A system comprising: a light source configured to generate light toward one or more surfaces or materials to inactivate one or more pathogens on the one or more surfaces or materials in an environment for human occupancy, the light including an inactivating portion having peak wavelength in a range of greater than 300 nanometers to below 380 nanometers. 2. The system of claim 1 , wherein the one or more pathogens that are inactivated by at least the inactivating portion of the light includes one or more of staphylococcus, clostridium, or streptococcus. 3. The system of claim 1 , wherein the light source is configured to generate the light toward the one or more surfaces or materials while also concurrently exposing one or more human beings to the light. 4. The system of claim 1 , wherein the light source is configured to generate the light toward the one or more surfaces or materials to inactivate the one or more pathogens without using a photosensitizer. 5. The system of claim 1 , wherein the light source is configured to generate the light so that the inactivating portion of the light is imperceptible to a human observer of the light. 6. The system of claim 1 , wherein the light source is configured to generate the inactivating portion of the light such that the inactivating portion of the light includes no more than 0.00015 watts of actinic ultraviolet light per square meter of floor area. 7. The system of claim 1 , wherein the light source is configured to generate the inactivating portion of the light such that the inactivating portion of the light includes no more than 0.5 watts per square meter of floor area of ultraviolet A light. 8. The system of claim 1 , wherein the light source is configured to generate no more than 11 watts of blue light per steradian per square meter. 9. The system of claim 1 , wherein the light source is configured to generate the inactivating portion of the light such that the inactivating portion of the light includes no more than 0.001 watts of actinic ultraviolet light per square meter of floor area. 10. The system of claim 1 , wherein the light source is configured to generate the inactivating portion of the light such that the inactivating portion of the light includes no more than 10 watts of ultraviolet A light per square meter of floor area. 11. The system of claim 1 , wherein the light source is configured to generate no more than 100 watts of blue light per steradian per square meter. 12. The system of claim 1 , wherein the light source is configured to generate the inactivating portion of the light such that the inactivating portion of the light includes no more than 0.003 watts of actinic ultraviolet light per square meter of floor area. 13. The system of claim 1 , wherein the light source is configured to generate the inactivating portion of the light such that the inactivating portion of the light includes no more than 33 watts of ultraviolet A light per square meter of floor area. 14. The system of claim 1 , wherein the light source is configured to generate no more than 10,000 watts of blue light per steradian per square meter. 15. The system of claim 1 , wherein the light source is configured to generate the light such that the inactivating portion of the light includes wavelengths in a range of 320 to 380 nm. 16. The system of claim 1 , wherein the light source is configured to generate the light such that the inactivating portion of the light has a peak wavelength in a range of 320 to 370 nm. 17. The system of claim 1 , wherein the light source is configured to generate the light such that the inactivating portion of the light is pulsed at a frequency exceeding 100 hertz with a duty factor of less than 0.5. 18. The system of claim 1 , wherein the light source is configured to generate the light such that the inactivating portion of the light is pulsed at a frequency exceeding 100 hertz with a duty factor of less than 0.1. 19. The system of claim 1 , wherein the light source generates the light to include the inactivating portion of the light with wavelengths in a range of 280 to 380 nanometers, and a second portion of the light having longer wavelengths. 20. A method comprising: generating light from a light source toward one or more surfaces or materials to inactivate one or more pathogens on the one or more surfaces or materials in an environment for human occupancy, the light generated at a power density of no more than five watts per square meter at an exposed area of the one or more surfaces or materials with an inactivating portion of the light including peak wavelengths in a range of greater than 300 nanometers to below 380 nanometers. 21. The method of claim 20 , wherein the one or more pathogens that are inactivated by at least the inactivating portion of the light includes one or more of staphylococcus, clostridium difficile, or streptococcus. 22. The method of claim 20 , wherein the light source is configured to generate the light toward the one or more surfaces or materials while also concurrently exposing one or more human beings to the light. 23. A system comprising: a light source configured to generate light toward one or more surfaces or materials to inactivate one or more pathogens on the one or more surfaces or materials in an environment for human occupancy, the light including an inactivating portion having wavelengths in a range of 280 to below 380 nanometers, wherein the light source is configured to generate the light such that the inactivating portion of the light has peak wavelength in a range of 320 to 370 nm. 24. The system of claim 23 , wherein the light source is configured to generate no more than 100 watts of blue light per steradian per square meter. 25. The system of claim 23 , wherein the light source is configured to generate the light so that the inactivating portion of the light is imperceptible to a human observer of the light.

Assignees

Inventors

Classifications

  • Room floors or walls · CPC title

  • Apparatus for generating biocidal substances, e.g. vaporisers, UV lamps · CPC title

  • Human Necessities · mapped topic

  • A61L2/10Primary

    Ultraviolet [UV] radiation · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US9937274B2 cover?
A lighting system includes a light source configured to generate light toward one or more surfaces or materials to inactivate one or more pathogens on the one or more surfaces or materials. The light includes an inactivating portion having wavelengths in a range of 280 to 380 nanometers.
Who is the assignee on this patent?
Ge Lighting Solutions Llc
What technology area does this patent fall under?
Primary CPC classification A61L2/10. Mapped technology areas include Human Necessities.
When was this patent published?
Publication date Tue Apr 10 2018 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 1 related publication on this page (citations in our corpus or others sharing the same primary CPC).